Everyday HealthBispecific Antibody Shows Promise in R/R Multiple Myeloma

Publication: The LancetDesign: Open-label, single-arm study of 157 patients who had undergone a median of six previous lines of therapy and who received at least one dose of teclistamab; 40 patients received the recommended phase II dose of teclistamabResults: Of the 40 receiving the phase II dose, 58% achieved a very good partial response or […]

Everyday HealthDoubling Semaglutide Dose Helps Get HbA1c Under Control

According to the SUSTAIN FORTE study presented online in The Lancet Diabetes & Endocrinology, doubling the dose of semaglutide (Ozempic) might be a helpful option for people not achieving glycemic goals. Still, some researchers aren’t convinced this is a sound strategy – “statistically significant but barely clinically relevant” — suggesting opting for another agent when […]